Dodge & Cox holds 6.9% of GE HealthCare (GEHC) shares

Rhea-AI Filing Summary

Dodge & Cox has disclosed a significant holding in GE HealthCare Technologies Inc. The firm reports beneficial ownership of 31,211,229 shares of GE HealthCare common stock, representing 6.9% of the class as of 12/31/2025.

Dodge & Cox has sole power to vote 29,588,129 shares and sole power to dispose of 31,211,229 shares, with no shared voting or dispositive power. The shares are held for clients of Dodge & Cox, who have the right to receive dividends and sale proceeds. Dodge & Cox certifies the position is held in the ordinary course of business and not for the purpose of changing or influencing control of GE HealthCare.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 01:22 PM Learn about SEC filing dates

FAQ

What percentage of GEHC does Dodge & Cox report owning in this Schedule 13G/A?

Dodge & Cox reports beneficial ownership of 6.9% of GE HealthCare’s common stock. This corresponds to 31,211,229 shares as of December 31, 2025, making Dodge & Cox a significant institutional holder of GE HealthCare Technologies Inc. shares.

How many GEHC shares does Dodge & Cox have voting and dispositive power over?

Dodge & Cox has sole voting power over 29,588,129 shares and sole dispositive power over 31,211,229 shares. It reports no shared voting or dispositive power, indicating centralized control of how these shares are voted and potentially sold.

Who ultimately benefits from Dodge & Cox’s GEHC share holdings?

The clients of Dodge & Cox, including investment companies and other managed accounts, have the right to receive dividends and sale proceeds from the GE HealthCare shares. Dodge & Cox manages these holdings on their behalf as part of its advisory role.

What does Dodge & Cox state about its intent regarding control of GE HealthCare?

Dodge & Cox certifies the GE HealthCare shares were acquired and are held in the ordinary course of business and not for changing or influencing control of the company, nor in connection with any transaction intended to have that purpose or effect.

What type of SEC filing is this GEHC ownership report from Dodge & Cox?

This disclosure is an Amendment No. 1 to a Schedule 13G for GE HealthCare Technologies Inc. Schedule 13G is used to report beneficial ownership of more than 5% of a class of securities when held in a primarily passive, non‑control capacity.

On what date is Dodge & Cox’s GEHC ownership information reported as of?

The ownership information is reported as of December 31, 2025. As of that date, Dodge & Cox beneficially owned 31,211,229 GE HealthCare shares, representing 6.9% of the company’s common stock, with specified voting and dispositive powers.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

GE HEALTHCARE TECHNOLOGIES INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

36266G107

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 36266G107

1

Names of Reporting Persons

Dodge & Cox

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 29,588,129.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 31,211,229.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

31,211,229.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GE HEALTHCARE TECHNOLOGIES INC.
(b)	Address of issuer's principal executive offices: 500 W. Monroe Street, Chicago, IL 60661
Item 2.
(a)	Name of person filing: Dodge & Cox
(b)	Address or principal business office or, if none, residence: 555 California Street 40th Floor, San Francisco, CA 94104
(c)	Citizenship: California, USA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 36266G107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 31,211,229
(b)	Percent of class: 6.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 29,588,129
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 31,211,229
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The clients of Dodge & Cox, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, GE HEALTHCARE TECHNOLOGIES INC.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dodge & Cox

Signature:	/S/ Katherine M. Primas
Name/Title:	Chief Compliance Officer
Date:	02/13/2026